AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
26.28
-1.52 (-5.47%)
At close: May 8, 2026, 4:00 PM EDT
26.80
+0.52 (1.98%)
After-hours: May 8, 2026, 5:38 PM EDT
AtriCure Market Cap
AtriCure has a market cap or net worth of $1.33 billion as of May 8, 2026. Its market cap has decreased by -19.33% in one year.
Market Cap
1.33B
Enterprise Value
1.26B
1-Year Change
-19.33%
Ranking
Category
Stock Price
$26.28
Market Cap Chart
Since August 5, 2005, AtriCure's market cap has increased from $167.60M to $1.33B, an increase of 694.06%. That is a compound annual growth rate of 10.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.33B | -32.34% |
| Dec 31, 2025 | 1.97B | 32.01% |
| Dec 31, 2024 | 1.49B | -11.92% |
| Dec 29, 2023 | 1.69B | -18.05% |
| Dec 30, 2022 | 2.06B | -35.37% |
| Dec 31, 2021 | 3.19B | 27.42% |
| Dec 31, 2020 | 2.51B | 94.93% |
| Dec 31, 2019 | 1.29B | 9.07% |
| Dec 31, 2018 | 1.18B | 87.48% |
| Dec 29, 2017 | 628.80M | -3.34% |
| Dec 30, 2016 | 650.50M | -10.02% |
| Dec 31, 2015 | 722.90M | 31.84% |
| Dec 31, 2014 | 548.30M | 39.66% |
| Dec 31, 2013 | 392.60M | 241.09% |
| Dec 31, 2012 | 115.10M | -36.16% |
| Dec 30, 2011 | 180.30M | 12.62% |
| Dec 31, 2010 | 160.10M | 73.08% |
| Dec 31, 2009 | 92.50M | 192.72% |
| Dec 31, 2008 | 31.60M | -82.95% |
| Dec 31, 2007 | 185.30M | 70.16% |
| Dec 29, 2006 | 108.90M | -15.25% |
| Dec 30, 2005 | 128.50M | -23.33% |
| Aug 5, 2005 | 167.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ICU Medical | 3.16B |
| LeMaitre Vascular | 2.47B |
| DENTSPLY SIRONA | 2.20B |
| Alamar Biosciences | 1.63B |
| STAAR Surgical Company | 1.32B |
| Pulse Biosciences | 1.30B |
| Kestra Medical Technologies | 1.23B |
| Anbio Biotechnology | 1.13B |